Plus Therapeutics, Inc. | CYTX - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $-5658000 in Pre-Tax Profit for its fiscal quarter ending in December of 2022.


Pre Tax Profit Change
Baxter International BAX:US USD 387M 147M
Cerus CERS:US USD -15564000 2.21M
Dr.Reddys Laboratories DRRD:IN INR 13.83B 2.68B
Haemonetics HAE:US USD 51.31M 6.64M
Infinity Pharmaceuticals INFI:US USD -11045000 1.82M
Mirati Therapeutics MRTX:US USD -184586000 17.63M
Sun Pharmaceuticals SUNP:IN INR 24.11B 603.3M
Teva Pharmaceutical Industries Ltd TEVA:IT USD -258000000 842M